去唾液酸糖蛋白受体在肝脏疾病诊治中的应用及研究进展  

Application and research progress of asialoglycoprotein receptor in the diagnosis and treatment of liver diseases

作　　者：胡虎兰 姚金金 HU Hulan;YAO Jinjin(Department of Gastroenterology,Hangzhou Ninth People's Hospital,Hangzhou 311225,China;Department of Pharmacy,the Affiliated Hospital of Hangzhou Normal University,Hangzhou 310015,China)

机构地区：[1]杭州市第九人民医院消化内科,浙江杭州311225 [2]杭州师范大学附属医院药剂科,浙江杭州310015

出　　处：《健康研究》2021年第4期416-419,427,共5页Health Research

基　　金：杭州市医药卫生科技项目(OO20190605)。

摘　　要：文章综述肝脏疾病的流行病学现状、去唾液酸糖蛋白受体(asialoglycoprotein receptor,ASGPR)在肝脏疾病诊治中的应用及研究进展。目前基于ASGPR制备的新型制剂亟待进一步深入研究,以发挥其更大的临床价值。This paper reviewed the current epidemiological situation of liver diseases,the application of asialoglycoprotein receptor(ASGPR)in the diagnosis and treatment of liver diseases and the research progress.The new formulation based on ASGPR needs to be further investigated in order to applicant more clinical value.

关 键 词：去唾液酸糖蛋白受体 肝脏疾病 应用 

分 类 号：R575[医药卫生—消化系统]